Advarra

Artificial intelligence + machine learning have the promise to revolutionize the field of clinical research, streamlining processes, removing redundant work, accelerating timelines, and improving outcomes. Check out Advarra Chief Technology Officer Jeff Sidell's latest blog for insights on preparing for the rapidly evolving technological landscape and ethical integration of AI into patient care and research practices. #HealthcareInnovation #HealthcareTechnology #AI #ClinicalResearch

Thank you to everyone who joined our #PRIMR24 sIRB breakfast session this morning! Thanks Joshua Fedewa for leading the conversation. No matter the regulatory weather, this community always figures it out together. ??

Speed, not silos. Our SVP of Site-Sponsor Innovation, Christine Senn, PhD, recently joined Jimmy Bechtel, MBA, VP of Site Engagement for the Society for Clinical Research Sites (SCRS), on the SCRS Talks podcast to discuss how the clinical research industry can move from siloed processes to integrated collaborations between sponsors, CROs, and sites. Christine shares personal insights on a collaborative approach to change that begins with removing internal process silos and communicating more effectively for the greater good. The result? Accelerated timelines, reduced costs, and improved patient access to trials. ?? Listen to the podcast here to dive into the challenges of study startup and the risks posed by working in isolation: https://lnkd.in/g5HNXiVy #ClinicalResearch #ClinicalTrials #HealthcareInnovation

The Advarra team is at the annual PRIMR Conference in Seattle this week! Come see us at booth #101 and swing by our designated office space on the exhibit floor to catch up on emails or grab a charge. We're looking forward to learning, connecting, and collaborating on advancing ethical, responsible, and high-quality research with our community. Check out the Advarra speaker lineup below. Luke Gelinas James Riddle Daniel Eisenman PhD, CBSP Joshua Fedewa Julie Ozier #PRIMR2024 #ResearchEthics #ClinicalResearch #ClinicalTrials

Earlier this week, we published the 2024 Site-Sponsor-CRO Collaboration Survey Report, which provides an in-depth look at the current challenges impacting collaboration between sites, sponsors, and CROs, drawing perspective from a survey of 200+ clinical research professionals. The bottom line: relationships between sites and sponsors/CROs are universally agreed to be complicated, and one area all survey respondents aligned on is concerns about complexity and efficiency in the clinical trial process. These misalignment challenges are impacting trial execution, but there's a path forward. ?? Check out the survey report here to discover data and insights that will drive meaningful changes to accelerate research, including five actions organizations can take now to improve collaboration: https://lnkd.in/gwgjYky5 #ClinicalResearch #ClinicalTrials #HealthcareInnovation

Heading to PRIM&R 2024 in Seattle? Don't miss this session from Advarra's Daniel Eisenman PhD, CBSP, Melissa Heidelberg, B.S., M.S. Bioethics of Takeda, and Susan Kornetsky, MPH of Boston Children's Hospital! Gain insights from these research community experts about... - Elements of cell and gene therapy trials requiring special ethical considerations - Informed consent challenges in cell and gene therapy research - Best practices for equitable participant recruitment and engagement in medically underserved communities and low resource countries Will you be at #PRIMR2024? Hope to see you there! More info + full agenda here: https://lnkd.in/gynceayf #ClinicalResearch #ClinicalTrials #CellGeneTherapy

Great insights on our newly released 2024 Site-Sponsor-CRO Collaboration Survey Report from Advarra SVP of Site-Sponsor Innovation Christine Senn, PhD.

The 2024 Site-Sponsor-CRO Collaboration Survey Report is live. ?? The report provides an in-depth look at the current challenges impacting collaboration between sites, sponsors, and CROs, capturing perspectives from 200+ clinical research professionals: ? Top challenges impacting collaboration between sites, sponsors, and CROs ? How these challenges impact trial execution ? Details on communication practices for improving collaboration ? Perceptions on technology’s role in contributing to stakeholder misalignment ? Five actions organizations can take to improve collaboration Check out the survey report here to discover data and insights that will drive meaningful changes to accelerate research: https://lnkd.in/gwgjYky5 #ClinicalResearch #ClinicalTrials #HealthcareInnovation

The International Council for Harmonisation (ICH) good clinical practice (GCP) guidelines are critical in ensuring the safety and rights of clinical trial participants, and they just got an update. ?? ICH GCP E6 R3 introduces quality by design, further refines risk management, and establishes clearer roles and responsibilities. The transition from R2 to R3 represents a significant evolution in the ICH guidelines – there are some key elements for sponsor organizations to focus on as they optimize clinical quality. Advarra Managing Director of GxP Services, Jeremy Allard, shares more insights in this blog: https://lnkd.in/gsk-rHCv #ClinicalResearch #ClinicalTrials #GCP

According to our 2023 Study Activation Survey, 56% of sites cite technology as the biggest burden among all study startup activities. Our SVP, Site-Sponsor Innovation, Christine Senn, PhD, recently spoke with fellow industry leaders to discuss that pain point, including insights on fragmented relationships between sites, sponsors, and CROs, and potential remedies and solutions. Thanks for sharing your perspective, Rosalie Filling! Read the full article here for more: https://lnkd.in/gJtsNHP6 Endo #ClinicalResearch #ClinicalTrials #HealthcareInnovation